David Porter, MD

Dr. Porter is the Jodi Fisher-Horowitz Professor of Leukemia Care Excellence at the Perelman School of Medicine and Abramson Cancer Center, and the Executive Director of the Center for Cell Therapy and Transplant at the University of Pennsylvania. Dr Porter chairs or serves on numerous local, national and international committees focused on hematologic malignancies, stem cell transplantation and cell therapy. He is a past Chair and emeritus member of the Board of Directors of the National Marrow Donor Program and currently serves as President-elect of the American Society for Transplantation and Cellular Therapy. He is the Deputy Editor of Transplantation and Cellular Therapy and is an Associate Editor for the American Journal of Hematology. Dr. Porter is an accomplished clinical investigator with research interests in development of novel approaches to cellular therapy and stem cell transplantation. He has an extensive publication record and has been the primary or co-author of over 200 research and review articles. Along with colleagues at the University of Pennsylvania he has pioneered the successful development of CAR T cells for cancer. Other research highlights include development of novel trials designed to prevent GVHD after allogeneic SCT by blocking lymphocyte trafficking, and studies to enhance graft-vs-tumor activity at the time of transplant, after non-myeloablative therapy, and for relapse after SCT.